Neonatal hypoglycaemia is common in at-risk infants and can cause adverse neurologic
outcomes in later life. Continuous glucose monitoring (CGM) technology offers a way to …

Continuous glucose monitoring (CGM) is well established in the management of diabetes
mellitus, but its role in neonatal glycaemic control is less clear. CGM has provided important …

Glycaemic control (GC) in the intensive care unit is contentious. Hyperglycaemia,
hypoglycaemia, and glycaemic variability are all associated with increased morbidity and …

Hypoglycaemia and hyperglycaemia are common in infants requiring intensive care and are
associated with worse clinical outcomes. However, glucose levels are taken infrequently …

Objective Recent studies have highlighted the need for improved methods of monitoring
glucose control in intensive care to reduce hyperglycaemia, without increasing the risk of …

Critically ill patients often exhibit abnormal glycaemia that can lead to severe complications
and potentially death. In critically ill adults, hyperglycaemia is a common problem that has …

The National Institute for Clinical Excellence (NICE) now recommends that continuous
glucose monitoring (CGM) be offered to adults and children with diabetes who are at risk …

Background Continuous glucose monitoring using subcutaneous sensors has been
validated in adults and children with diabetes, and was found to be useful in the …

Objective To evaluate the efficacy of a strict glycaemic control protocol using a continuous
glucose monitoring (CGM) in infants at high risk of dysglycaemia with the aim of reducing the …

Aim Postnatal hypoglycaemia increases the risk of adverse neurological outcomes in
newborn infants, and adequate glucose control requires repetitive and painful blood …